ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 350 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,478,751 | +9.2% | 5,764 | 0.0% | 0.01% | +9.1% |
| Q1 2024 | $2,269,402 | -13.8% | 5,764 | -16.8% | 0.01% | -26.7% |
| Q4 2023 | $2,634,097 | +77282.4% | 6,924 | 0.0% | 0.02% | -31.8% |
| Q3 2023 | $3,404 | +63.2% | 6,924 | +29.4% | 0.02% | +57.1% |
| Q2 2023 | $2,086 | +4.6% | 5,352 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,994 | -47.2% | 5,352 | -46.3% | 0.01% | -50.0% |
| Q4 2022 | $3,774 | -99.9% | 9,962 | 0.0% | 0.03% | +3.7% |
| Q3 2022 | $3,517,000 | -15.1% | 9,962 | -8.9% | 0.03% | -10.0% |
| Q2 2022 | $4,143,000 | +20.2% | 10,935 | 0.0% | 0.03% | +50.0% |
| Q1 2022 | $3,448,000 | -10.7% | 10,935 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $3,860,000 | +29.5% | 10,935 | +10.8% | 0.02% | +25.0% |
| Q3 2021 | $2,980,000 | +19.7% | 9,867 | +19.4% | 0.02% | +6.7% |
| Q2 2021 | $2,489,000 | +83.7% | 8,267 | +68.0% | 0.02% | +66.7% |
| Q1 2021 | $1,355,000 | – | 4,920 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |